Participated · Seed · Sep 2021

Colossal Biosciences focuses on applying AI to biological questions, including predicting how biological systems fail or break. The company is co-founded by Ben Lamm and has been associated publicly with figures such as George Church, Beth Shapiro, and Adam Milne. Financially, Colossal announced a $20 million financing at a $3.8 billion valuation. The recent capital raise is described as supporting its AI initiatives. The provided articles do not include revenue, user, or other operating metrics, nor do they state the company's founding year or location.

Participated · Seed · Sep 2021

Colossal is a newly announced company pursuing de-extinction by using CRISPR to genetically reengineer Asian elephants to be more like woolly mammoths. The project and company were announced by Harvard scientist George Church and his colleagues. The effort plans to apply gene-editing technology to recreate mammoth-like traits in elephants. The company disclosed it has raised $15 million to fund the work. Named backers include billionaire Thomas Tull and venture capital firms Breyer Capital and Draper Associates. Church said the mammoth work had previously received very little direct funding, under $10,000 a year.